These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11179489)
1. Intravenous readministration of an adenoviral vector performed long after the initial administration failed to induce re-expression of the original transgene in rats. Tsujinoue H; Kuriyama S; Tominaga K; Okuda H; Nakatani T; Yoshiji H; Tsujimoto T; Akahane T; Asada K; Fukui H Int J Oncol; 2001 Mar; 18(3):575-80. PubMed ID: 11179489 [TBL] [Abstract][Full Text] [Related]
2. Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver. Kuriyama S; Tominaga K; Kikukawa M; Tsujimoto T; Nakatani T; Tsujinoue H; Okuda H; Nagao S; Mitoro A; Yoshiji H; Fukui H Gene Ther; 1999 May; 6(5):749-57. PubMed ID: 10505097 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver. Kuriyama S; Tominaga K; Mitoro A; Tsujinoue H; Nakatani T; Yamazaki M; Nagao S; Toyokawa Y; Okamoto S; Fukui H Int J Cancer; 2000 Mar; 85(6):839-44. PubMed ID: 10709105 [TBL] [Abstract][Full Text] [Related]
4. Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies. Tominaga K; Kuriyama S; Yoshiji H; Deguchi A; Kita Y; Funakoshi F; Masaki T; Kurokohchi K; Uchida N; Tsujimoto T; Fukui H Gut; 2004 Aug; 53(8):1167-73. PubMed ID: 15247187 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration. Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice. Nagao S; Kuriyama S; Okuda H; Tominaga K; Nakatani T; Tsujinoue H; Yoshiji H; Fukui H Int J Oncol; 2001 Jan; 18(1):57-65. PubMed ID: 11115539 [TBL] [Abstract][Full Text] [Related]
7. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver. Herrmann J; Abriss B; van de Leur E; Weiskirchen S; Gressner AM; Weiskirchen R Arch Virol; 2004 Aug; 149(8):1611-7. PubMed ID: 15290384 [TBL] [Abstract][Full Text] [Related]
9. Repetitive and safe transgene expression in rat liver is achievable by adenoviral infusion into the common bile duct. Kuriyama S; Yoshiji H; Tominaga K; Tsujinoue H; Nakatani T; Tsujimoto T; Okuda H; Akahane T; Deguchi A; Nakai S; Masaki T; Uchida N Int J Mol Med; 2005 Oct; 16(4):503-8. PubMed ID: 16142379 [TBL] [Abstract][Full Text] [Related]
10. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Croyle MA; Chirmule N; Zhang Y; Wilson JM Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620 [TBL] [Abstract][Full Text] [Related]
11. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428 [TBL] [Abstract][Full Text] [Related]
12. Liver-directed gene transfer in non-human primates. Sullivan DE; Dash S; Du H; Hiramatsu N; Aydin F; Kolls J; Blanchard J; Baskin G; Gerber MA Hum Gene Ther; 1997 Jul; 8(10):1195-206. PubMed ID: 9215737 [TBL] [Abstract][Full Text] [Related]
13. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. Ilan Y; Attavar P; Takahashi M; Davidson A; Horwitz MS; Guida J; Chowdhury NR; Chowdhury JR J Clin Invest; 1996 Dec; 98(11):2640-7. PubMed ID: 8958229 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Nunes FA; Furth EE; Wilson JM; Raper SE Hum Gene Ther; 1999 Oct; 10(15):2515-26. PubMed ID: 10543616 [TBL] [Abstract][Full Text] [Related]
15. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Parks R; Evelegh C; Graham F Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Jooss K; Yang Y; Wilson JM Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756 [TBL] [Abstract][Full Text] [Related]